US Stock MarketDetailed Quotes

Ionis Pharmaceuticals (IONS)

Watchlist
  • 73.270
  • -0.820-1.11%
Close Apr 24 16:00 ET
  • 73.270
  • 0.0000.00%
Post 19:24 ET
12.10BMarket Cap-30.79P/E (TTM)

Ionis Pharmaceuticals (IONS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
33.83%943.71M
-10.26%203.33M
17.12%156.72M
100.69%452.05M
10.14%131.61M
-10.48%705.14M
-30.18%226.58M
-7.21%133.81M
19.55%225.25M
-8.45%119.5M
Operating revenue
33.83%943.71M
-10.26%203.33M
17.12%156.72M
100.69%452.05M
10.14%131.61M
-10.48%705.14M
-30.18%226.58M
-7.21%133.81M
19.55%225.25M
-8.45%119.5M
Cost of revenue
41.85%15.91M
107.75%7.96M
118.30%2.34M
-0.31%4.15M
-31.82%1.5M
22.80%11.22M
25.08%3.83M
-51.12%1.07M
64.13%4.16M
63.81%2.2M
Gross profit
33.70%927.8M
-12.29%195.37M
16.30%154.38M
102.59%447.9M
10.93%130.11M
-10.87%693.92M
-30.70%222.75M
-6.53%132.74M
18.94%221.09M
-9.20%117.3M
Operating expense
12.02%1.31B
22.86%409.85M
11.80%314.55M
7.28%308.06M
3.84%277.06M
3.25%1.17B
1.84%333.59M
-1.39%281.36M
4.02%287.16M
9.65%266.82M
Selling and administrative expenses
47.25%393.9M
47.79%130.2M
57.14%96.8M
39.17%90.6M
45.06%76.3M
14.99%267.5M
24.05%88.1M
-12.00%61.6M
41.09%65.1M
15.56%52.6M
-General and administrative expense
47.25%393.9M
47.79%130.2M
57.14%96.8M
39.17%90.6M
45.06%76.3M
15.00%267.5M
24.08%88.1M
-12.00%61.6M
--65.1M
15.56%52.6M
Research and development costs
1.56%915.62M
13.91%279.65M
-0.91%217.75M
-2.07%217.46M
-6.28%200.76M
0.21%901.53M
-4.31%245.49M
2.06%219.76M
-3.42%222.06M
8.29%214.22M
Operating profit
19.66%-381.72M
-93.49%-214.47M
-7.77%-160.17M
311.63%139.84M
1.72%-146.95M
-34.31%-475.11M
-1,707.93%-110.84M
-3.70%-148.62M
26.74%-66.08M
-30.99%-149.52M
Net non-operating interest income expense
0.41%-90.08M
2.66%-22.26M
2.56%-22.15M
0.17%-22.75M
-3.44%-22.92M
-11.05%-90.46M
-2.05%-22.87M
-3.43%-22.73M
-14.24%-22.79M
-29.41%-22.16M
Non-operating interest income
----
----
----
----
----
----
----
----
----
--49K
Non-operating interest expense
-0.68%83.78M
-3.33%20.56M
-3.21%20.55M
-6.75%21.25M
4.20%21.42M
3.56%84.36M
-20.37%21.27M
4.19%21.23M
14.24%22.79M
29.93%20.56M
Total other finance cost
3.28%6.3M
6.25%1.7M
6.67%1.6M
--1.5M
-6.25%1.5M
3.39%6.1M
0.00%1.6M
-6.25%1.5M
----
23.08%1.6M
Other net income (expense)
-12.65%92.13M
-67.23%8.73M
98.00%53.95M
-71.44%6.48M
-20.51%22.97M
4.19%105.46M
3.42%26.64M
11.50%27.25M
-30.64%22.68M
57.65%28.9M
Gain on sale of security
3.70%107.99M
-3.13%25.52M
97.70%53.59M
-71.11%6.38M
-21.37%22.5M
19.52%104.13M
3.20%26.34M
23.26%27.11M
2.58%22.07M
58.13%28.62M
Other non- operating income (expenses)
-1,291.44%-15.86M
-5,658.61%-16.79M
155.63%363K
-83.28%102K
67.87%465K
-90.56%1.33M
26.89%302K
-94.20%142K
-94.55%610K
20.43%277K
Income before tax
17.49%-379.6M
-112.93%-227.92M
10.90%-128.39M
286.60%123.53M
-2.87%-146.82M
-37.76%-460.07M
-3,768.41%-107.04M
-2.34%-144.1M
14.52%-66.2M
-26.37%-142.73M
Income tax
128.94%1.79M
154.94%1.48M
105.88%213K
-131.25%-20K
54.67%116K
-119.09%-6.17M
-141.41%-2.69M
-154.85%-3.62M
-99.18%64K
-99.34%75K
Net income
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
Net income continuous Operations
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
Minority interest income
Net income attributable to the parent company
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.97%-381.39M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-23.92%-453.9M
-1,026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
-14.86%-142.8M
Basic earnings per share
21.71%-2.38
-113.64%-1.41
15.79%-0.8
273.33%0.78
5.10%-0.93
-18.75%-3.04
-1,000.00%-0.66
7.77%-0.95
25.00%-0.45
-12.64%-0.98
Diluted earnings per share
21.71%-2.38
-113.64%-1.41
15.79%-0.8
255.56%0.7
5.10%-0.93
-18.75%-3.04
-1,000.00%-0.66
7.77%-0.95
25.00%-0.45
-12.64%-0.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 33.83%943.71M-10.26%203.33M17.12%156.72M100.69%452.05M10.14%131.61M-10.48%705.14M-30.18%226.58M-7.21%133.81M19.55%225.25M-8.45%119.5M
Operating revenue 33.83%943.71M-10.26%203.33M17.12%156.72M100.69%452.05M10.14%131.61M-10.48%705.14M-30.18%226.58M-7.21%133.81M19.55%225.25M-8.45%119.5M
Cost of revenue 41.85%15.91M107.75%7.96M118.30%2.34M-0.31%4.15M-31.82%1.5M22.80%11.22M25.08%3.83M-51.12%1.07M64.13%4.16M63.81%2.2M
Gross profit 33.70%927.8M-12.29%195.37M16.30%154.38M102.59%447.9M10.93%130.11M-10.87%693.92M-30.70%222.75M-6.53%132.74M18.94%221.09M-9.20%117.3M
Operating expense 12.02%1.31B22.86%409.85M11.80%314.55M7.28%308.06M3.84%277.06M3.25%1.17B1.84%333.59M-1.39%281.36M4.02%287.16M9.65%266.82M
Selling and administrative expenses 47.25%393.9M47.79%130.2M57.14%96.8M39.17%90.6M45.06%76.3M14.99%267.5M24.05%88.1M-12.00%61.6M41.09%65.1M15.56%52.6M
-General and administrative expense 47.25%393.9M47.79%130.2M57.14%96.8M39.17%90.6M45.06%76.3M15.00%267.5M24.08%88.1M-12.00%61.6M--65.1M15.56%52.6M
Research and development costs 1.56%915.62M13.91%279.65M-0.91%217.75M-2.07%217.46M-6.28%200.76M0.21%901.53M-4.31%245.49M2.06%219.76M-3.42%222.06M8.29%214.22M
Operating profit 19.66%-381.72M-93.49%-214.47M-7.77%-160.17M311.63%139.84M1.72%-146.95M-34.31%-475.11M-1,707.93%-110.84M-3.70%-148.62M26.74%-66.08M-30.99%-149.52M
Net non-operating interest income expense 0.41%-90.08M2.66%-22.26M2.56%-22.15M0.17%-22.75M-3.44%-22.92M-11.05%-90.46M-2.05%-22.87M-3.43%-22.73M-14.24%-22.79M-29.41%-22.16M
Non-operating interest income --------------------------------------49K
Non-operating interest expense -0.68%83.78M-3.33%20.56M-3.21%20.55M-6.75%21.25M4.20%21.42M3.56%84.36M-20.37%21.27M4.19%21.23M14.24%22.79M29.93%20.56M
Total other finance cost 3.28%6.3M6.25%1.7M6.67%1.6M--1.5M-6.25%1.5M3.39%6.1M0.00%1.6M-6.25%1.5M----23.08%1.6M
Other net income (expense) -12.65%92.13M-67.23%8.73M98.00%53.95M-71.44%6.48M-20.51%22.97M4.19%105.46M3.42%26.64M11.50%27.25M-30.64%22.68M57.65%28.9M
Gain on sale of security 3.70%107.99M-3.13%25.52M97.70%53.59M-71.11%6.38M-21.37%22.5M19.52%104.13M3.20%26.34M23.26%27.11M2.58%22.07M58.13%28.62M
Other non- operating income (expenses) -1,291.44%-15.86M-5,658.61%-16.79M155.63%363K-83.28%102K67.87%465K-90.56%1.33M26.89%302K-94.20%142K-94.55%610K20.43%277K
Income before tax 17.49%-379.6M-112.93%-227.92M10.90%-128.39M286.60%123.53M-2.87%-146.82M-37.76%-460.07M-3,768.41%-107.04M-2.34%-144.1M14.52%-66.2M-26.37%-142.73M
Income tax 128.94%1.79M154.94%1.48M105.88%213K-131.25%-20K54.67%116K-119.09%-6.17M-141.41%-2.69M-154.85%-3.62M-99.18%64K-99.34%75K
Net income 15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M-14.86%-142.8M
Net income continuous Operations 15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M-14.86%-142.8M
Minority interest income
Net income attributable to the parent company 15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M-14.86%-142.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.97%-381.39M-119.83%-229.39M8.45%-128.61M286.45%123.55M-2.90%-146.94M-23.92%-453.9M-1,026.51%-104.35M4.70%-140.48M22.31%-66.27M-14.86%-142.8M
Basic earnings per share 21.71%-2.38-113.64%-1.4115.79%-0.8273.33%0.785.10%-0.93-18.75%-3.04-1,000.00%-0.667.77%-0.9525.00%-0.45-12.64%-0.98
Diluted earnings per share 21.71%-2.38-113.64%-1.4115.79%-0.8255.56%0.75.10%-0.93-18.75%-3.04-1,000.00%-0.667.77%-0.9525.00%-0.45-12.64%-0.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More